Determinants of compliance to influenza and COVID-19 vaccination in a cohort of solid organ transplant patients in Puglia, Southern Italy (2017-2022).

Pasquale Stefanizzi, Francesco Paolo Bianchi, Lorenza Moscara, Andrea Martinelli, Antonio Di Lorenzo, Loreto Gesualdo, Simona Simone, Maria Rendina, Silvio Tafuri
Author Information
  1. Pasquale Stefanizzi: Hygiene Unit - Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy.
  2. Francesco Paolo Bianchi: Hygiene Unit - Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy.
  3. Lorenza Moscara: Hygiene Unit - Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy.
  4. Andrea Martinelli: Hygiene Unit - Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy.
  5. Antonio Di Lorenzo: Hygiene Unit - Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy.
  6. Loreto Gesualdo: Nephrology, Dialysis and Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, Bari, Italy.
  7. Simona Simone: Nephrology, Dialysis and Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, Bari, Italy.
  8. Maria Rendina: Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
  9. Silvio Tafuri: Hygiene Unit - Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy. ORCID

Abstract

Influenza and Coronavirus Disease 2019 (COVID-19) vaccination are recommended in both solid organ transplant (SOT) candidates and recipients. In Puglia, Southern Italy, an active vaccination offer program has been activated targeting these patients. This study aims at investigating vaccination coverage (VC) for both vaccines in a SOT patients' cohort, as well as at identifying the vaccination compliance determinant. This is a retrospective, population-based study. The study population consists of the SOT patients who accessed Bari's "Policlinico" General Hospital during 2017-2022. Patients were contacted and, after providing their consent, asked their immunization status regarding influenza and COVID-19 and whether they had already undergone transplant or were waiting to do so. Regression models were fitted to investigate the determinants of VCs for influenza vaccination (2021/22 and 2022/23 seasons) and for COVID-19 vaccination (three-dose base cycle, first and second booster doses). Three-hundred and ten SOT patients were identified; 85.2% (264/310) had already undergone SOT. VCs were suboptimal, especially for constant yearly influenza vaccination (17.7%) and COVID-19 vaccination's second booster (1.94%). Logistic regression highlighted that influenza VCs are higher for SOT recipients than SOT candidates, as well as for older patients, although when considering both vaccination seasons only age significantly impact the vaccination uptake. Older age was the only influential variable for COVID-19 VC. VCs for SOT patients seem to be unsatisfying. Stronger interventions are required.

Keywords

References

  1. Am J Transplant. 2021 May;21(5):1789-1800 [PMID: 33131188]
  2. Am J Infect Control. 2018 Jan;46(1):e9-e11 [PMID: 29167031]
  3. Hum Vaccin Immunother. 2017 Feb;13(2):346-350 [PMID: 27929758]
  4. Curr Transplant Rep. 2022;9(1):35-47 [PMID: 35096509]
  5. Vaccine. 2022 Aug 12;40(34):5030-5043 [PMID: 35863934]
  6. Am J Transplant. 2022 Jun;22(6):1705-1713 [PMID: 35143100]
  7. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-2 [PMID: 34893012]
  8. PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961 [PMID: 33332359]
  9. J Med Ethics. 2022 Apr;48(4):240-243 [PMID: 33637609]
  10. Viruses. 2021 Feb 26;13(3): [PMID: 33652829]
  11. Am J Transplant. 2021 Aug;21(8):2916-2918 [PMID: 34101990]
  12. Vaccines (Basel). 2022 Jul 27;10(8): [PMID: 36016081]
  13. Transpl Infect Dis. 2023 Apr;25(2):e14010 [PMID: 36715676]
  14. Vaccines (Basel). 2021 Oct 07;9(10): [PMID: 34696252]
  15. Exp Clin Transplant. 2022 Sep;20(9):805-810 [PMID: 36169102]
  16. J Med Virol. 2000 May;61(1):85-93 [PMID: 10745238]
  17. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-8 [PMID: 35021017]
  18. Front Public Health. 2023 Apr 03;11:1144659 [PMID: 37077191]
  19. Clin J Am Soc Nephrol. 2010 Sep;5(9):1637-41 [PMID: 20595695]
  20. Semin Respir Crit Care Med. 2011 Aug;32(4):471-93 [PMID: 21858751]
  21. Vaccines (Basel). 2021 May 04;9(5): [PMID: 34064483]
  22. Ann Pharmacother. 2012 Feb;46(2):255-64 [PMID: 22234989]
  23. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-6 [PMID: 34435938]
  24. Clin Microbiol Infect. 2022 Aug;28(8):1057-1065 [PMID: 35289294]
  25. Transpl Infect Dis. 2021 Jun;23(3):e13537 [PMID: 33258216]
  26. Int Immunopharmacol. 2021 Oct;99:108021 [PMID: 34352567]
  27. Am J Transplant. 2021 Mar;21(3):925-937 [PMID: 33319449]
  28. Front Public Health. 2022 Mar 10;10:855468 [PMID: 35356022]
  29. Biomed Res Int. 2019 Jul 4;2019:6764154 [PMID: 31355274]
  30. Vaccine. 2009 Apr 14;27(17):2335-41 [PMID: 19428848]
  31. J Adv Nurs. 2022 Sep;78(9):2894-2903 [PMID: 35301774]
  32. Transplantation. 2021 Jan 1;105(1):37-55 [PMID: 33148977]
  33. Transplant Direct. 2021 Jun 10;7(7):e713 [PMID: 34131585]
  34. Hum Vaccin Immunother. 2020 Sep 1;16(9):2136-2143 [PMID: 32614656]
  35. Front Public Health. 2022 Dec 15;10:1014942 [PMID: 36589975]
  36. Lancet Reg Health Am. 2022 Dec;16:100371 [PMID: 36185969]
  37. Int J Public Health. 2023 Mar 10;68:1605175 [PMID: 36968266]
  38. BMC Infect Dis. 2022 Oct 13;22(1):786 [PMID: 36229772]
  39. N Engl J Med. 2022 Mar 10;386(10):933-941 [PMID: 35020982]
  40. Vaccine. 2018 Feb 14;36(8):1072-1077 [PMID: 29358055]
  41. J Med Virol. 2023 Jan;95(1):e28377 [PMID: 36478241]
  42. RMD Open. 2022 Jan;8(1): [PMID: 34987092]
  43. Am J Transplant. 2022 Oct;22(10):2409-2417 [PMID: 35384275]
  44. Vaccine. 2023 Aug 31;41(38):5655-5661 [PMID: 37544827]
  45. Drugs. 2007;67(10):1411-27 [PMID: 17600390]
  46. Vaccines (Basel). 2023 Mar 23;11(4): [PMID: 37112629]
  47. JAMA. 2021 Jun 1;325(21):2204-2206 [PMID: 33950155]

MeSH Term

Humans
COVID-19
COVID-19 Vaccines
Influenza Vaccines
Influenza, Human
Italy
Organ Transplantation
Retrospective Studies
Transplant Recipients
Vaccination
Treatment Adherence and Compliance

Chemicals

COVID-19 Vaccines
Influenza Vaccines